Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) currently has a daily average trading volume of 706.50K but it saw 2537668 shares traded in last market. With a market cap of 5.66B USD, the company’s current market price of $89.04 came rising about 0.04 while comparing to the previous closing price of $89.0. In past 52 weeks, the stock remained buoying in the range of price level as high as $89.05 and as low as $40.61. In the recent trading on the day, stock has struck highest price mark of $87.39 while lowest mark touched by it was $94.8.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Goldman which initiated the stock as “Buy” in its note to investors issued on July 10, 2025, recommending a price target of $97 for it. BofA Securities issued its recommendations for the stock as it upgraded the price target for the stock is $63.
Over the week, RYTM’s stock price is moving 33.05% up while it is 33.45% when we observe its performance for the past one month. Year-to-date it is 103.47% up and over the past year, the stock is showing an upside performance of 59.06%.
Currently, Rhythm Pharmaceuticals Inc’s total number of outstanding shares is 63.49M. Company’s return on investment (ROI) stands at -63.30% and return on equity (ROE) at -418.97%. Stock’s beta reads 2.36. Stock has a price to book (P/B) ratio of 298.39 while price to sale or P/S ratio amounts to 41.39. Its return on asset (ROA) is -52.28% on average.
